FDA-Drug2022-02-02Class II
Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Aurobindo Pharma USA Inc.
Hazard
Superpotent and Failed Tablet/Capsule Specifications
Sold states
Nationwide in the US
Affected count
792 bottles
Manufactured in
279 Princeton Hightstown Rd, East Windsor, NJ, United States
Products
Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0450-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief